Resuming warfarin after GIB event decreases risk of thrombosis, death

Resuming warfarin after GIB event decreases risk of thrombosis, death

October 12, 2012

Patients who experience a warfarin-associated gastrointestinal tract bleeding event should resume anticoagulation therapy during the 90 days following the event to decrease the risk of thrombosis and death, according to a study published online in the Archives of Internal Medicine.